ADCY1 and type 2 diabetes mellitus: Adenosine A1 receptor (ADORA1), a G protein-coupled receptor, inhibits the enzyme adenylate cyclase and plays a role in the regulation of cell metabolism and gene transcription, and therefore, has been identified as an important drug target for the treatment of various diseases and illnesses [75,76], including T2DM via glucose homeostasis and glucagon secretion regulation [77].